FY2025 EPS Estimates for Spectral AI Cut by Northland Capmk

Key Points

• Northland Capital Market has reduced their FY2025 EPS estimates for Spectral AI from ($0.15) to ($0.35) per share, indicating a more pessimistic outlook for the company's financial performance.
• Spectral AI reported quarterly earnings of ($0.10) per share, missing the consensus estimate of ($0.07) by ($0.03) and generating revenue of $5.07 million, below expectations of $5.44 million.
• Hedge funds have been actively modifying their holdings in Spectral AI, with several purchasing new positions, indicating growing institutional interest in the stock despite its recent struggles.

Spectral AI, Inc. (NASDAQ:MDAI - Free Report) - Equities research analysts at Northland Capmk lowered their FY2025 earnings per share estimates for Spectral AI in a report released on Wednesday, August 13th. Northland Capmk analyst C. Byrnes now anticipates that the company will earn ($0.35) per share for the year, down from their prior estimate of ($0.15). The consensus estimate for Spectral AI's current full-year earnings is ($0.48) per share.

Spectral AI (NASDAQ:MDAI - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.03). The company had revenue of $5.07 million during the quarter, compared to analysts' expectations of $5.44 million. Spectral AI has set its FY 2025 guidance at EPS.

Separately, Wall Street Zen lowered Spectral AI from a "hold" rating to a "strong sell" rating in a report on Saturday, August 16th. One analyst has rated the stock with a Buy rating, According to MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $3.50.

Spectral AI Price Performance

MDAI traded up $0.07 on Monday, hitting $2.09. The company had a trading volume of 267,721 shares, compared to its average volume of 382,353. The company's fifty day moving average price is $2.42 and its 200 day moving average price is $1.84. Spectral AI has a 1-year low of $0.82 and a 1-year high of $3.25. The stock has a market cap of $52.92 million, a price-to-earnings ratio of -3.03 and a beta of 0.90.

Institutional Trading of Spectral AI

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Jane Street Group LLC acquired a new stake in Spectral AI in the 2nd quarter valued at approximately $74,000. Marshall Wace LLP acquired a new stake in Spectral AI in the 2nd quarter valued at approximately $104,000. XTX Topco Ltd acquired a new stake in Spectral AI in the 2nd quarter valued at approximately $123,000. DNB Asset Management AS acquired a new stake in Spectral AI in the 2nd quarter valued at approximately $107,000. Finally, Geode Capital Management LLC grew its holdings in Spectral AI by 21.8% in the 2nd quarter. Geode Capital Management LLC now owns 152,958 shares of the company's stock valued at $379,000 after buying an additional 27,365 shares during the last quarter. Institutional investors and hedge funds own 67.08% of the company's stock.

Spectral AI Company Profile

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.